Fujifilm to Buy Merck Units to Expand in Biologic Drugs
By Michael Silbergleid
Businessweek.com reports that Fujifilm, best known for its film and imaging equipment, will buy two units of Merck & Co. that make biopharmaceuticals as it targets growth in the health-care industry to make up for declining sales in cameras and film. The Tokyo-based maker of imaging equipment and digital cameras will acquire laboratories in the U.S. and U.K. for 40 billion yen ($490 million), Nikkei English News reported today without saying where it got the pricing information. Toshihiro Matsumoto, a Fujifilm spokesman, confirmed the purchase by phone today, without giving a price.